Phase III Trial Assessing the Efficacy and Safety of PXT3003 in CMT1A Patients (PLEO-CMT)
Summary
The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →
Investigators
The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.
- Florian Thomas, MD
Saint-Louis University, Saint-Louis, USA
Principal Investigator - Jack Puymirat, MD
University Hospital of Quebec
Principal Investigator - Marianne De Visser, MD
Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)
Principal Investigator - Mark Roberts, MD
Salford Royal NHS Foundation Trust, Manchester, UK
Principal Investigator - Peter Young, MD
University Hospital Munster, Germany
Principal Investigator - Philip Van Damme, MD
UZ Leuven, Belgium
Principal Investigator - Shahram Attarian, MD
CHU La Timone, Marseille, France
Principal Investigator - Teresa Sevilla, MD
Hospital Universitari i Politécnic La Fe, Valencia, Spain
Principal Investigator
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
30 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- Departement of Neurology, Uz Leuven
Leuven, Belgium
- University Hospital of Quebec
Québec, Quebec, Canada
- Centre de Référence Des Maladies Neuromusculaires, Hôpital Swynghedauwl, Chu de Lille
Lille, France
- Centre de Référence Des Neuropathies Périphériques Rares, Hôpital Dupuytren, Chu Limoges
Limoges, France
- Service de Neurologie Et Du Sommeil, Chu Lyon Sud
Lyon, France
- Centre de Référence Des Maladies Neuromusculaires, Pôle Des Neurosciences Clinique, Chu la Timone
Marseille, France
- Centre de Référence Des Maladies Neuromusculaires; Hôtel Dieu, Chu de Nantes
Nantes, France
- Service de Neurologie, Hôpital Kremlin Bicêtre
Paris, France
- Department of Neurology and Institute for Neuropathology, University Hospital Rwth Aachen
Aachen, Germany
- Department of Clinical Neurophysiology, University Medical Center Göttingen
Göttingen, Germany
- Department of Neurology, Ludwig-Maximillian University, Munich
Munich, Germany
- Department for Sleep Medicine and Neuromuscular, University Hospital Münster
Münster, Germany
- Departement of Neurology, Academic Medical Center
Amsterdam, Netherlands
- Department of Neurology, Hospital Univesitario de Bellvitge
Barcelona, Spain
- Servicio de Neurologia, Hospital Universitario la Paz
Madrid, Spain
- Centro de Diagnostico Y Tratamiento, Hospital Universitario Virgen del Rocio
Seville, Spain
- Servicio de Neurologia, Hospital Univesitari I Politécnic la Fe
Valencia, Spain
- Department of Neurology, Salford Royal Nhs Foundation Trust
Salford, Manchester, United Kingdom
- Ninewells Hospital and Medical School
Dundee, Scotland, United Kingdom
- Department of Neurology, Cedars-Sinai Medical Center
Los Angeles, California, United States
- Hospital for Special Care, New Britain
New Britain, Connecticut, United States
- Department of Neurology, Mcknight Brain Institute
Gainesville, Florida, United States
- University of Kansas Medical Center
Kansas City, Kansas, United States
- Brigham and Women'S Hospital
Boston, Massachusetts, United States
- University of Michigan Health System
Ann Arbor, Michigan, United States
- Department of Neurology, University of Minnesota
Minneapolis, Minnesota, United States
- Department of Neurology and Psichiatry, Saint Louis University
St Louis, Missouri, United States
- Peripheral Neuropathy Center, Neurological Institue Building, Columbia University Medical Center
New York, New York, United States
- Ohio State University
Columbus, Ohio, United States
- Saint Luke'S Rehabilitation Institute
Spokane, Washington, United States
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →
Registration & key dates
Registry attributes as recorded on the ClinicalTrials.gov study record.
- Start
- 31 Dec 2015
- Primary completion
- 31 Mar 2018
- Completion
- 31 Aug 2018
- Last update posted
- 27 Feb 2020
- Registered enrollment
- 323
- Registry id
- NCT02579759
Cross-registrations
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.